Research Progress on Antiviral Activity of Interferon-induced Transmembrane Proteins.
- Author:
Yongkun CHEN
;
Wenfei ZHU
;
Yuelong SHU
- Publication Type:Journal Article
- MeSH:
Animals;
Humans;
Interferons;
genetics;
immunology;
Membrane Proteins;
genetics;
immunology;
Virus Diseases;
genetics;
immunology;
virology;
Viruses;
genetics;
immunology
- From:
Chinese Journal of Virology
2016;32(2):222-228
- CountryChina
- Language:Chinese
-
Abstract:
Interferon-induced Transmembrane Proteins (IFITMs) were identified through small interference RNA (siRNA) screening method in 1980s. The antiviral properties of the IFITMs were firstly discovered in 1996. Recently, its antiviral effect and mechanism have become a research hotspot. Many studies have shown that IFITM can inhibit the replication of multiple pathogenic viruses, including influenza A virus (IAV), Human Immunodeficiency Virus (HIV-1), hepatitis C virus (HCV), Ebola virus (EBOV), West Nile virus and so on. IFITMs inhibit the replication of virus in the early stage of the viral life cycle, which occurred before the release of viral genomes into the cytosol. Recent studies indicate that IFITM proteins could block viral replication by mediate viral membrane fusion. However, the mechanism is still under investigation. Here we review the discovery and characterization of the IFITM proteins, elucidate their antiviral activities and the potential mechanisms.
